ZymoGenetics
ZymoGenetics, Inc. was a biopharmaceutical company based in Seattle, Washington. Founded in 1981 by a group of scientists from the University of Washington, it was one of the oldest biotechnology companies in the USA, focusing on the development and commercialization of therapeutic proteins. Originally an independent entity, ZymoGenetics became a subsidiary of Bristol-Myers Squibb in 2010.
History[edit | edit source]
ZymoGenetics was established to explore the rapidly evolving field of recombinant DNA technology. The company aimed to harness this technology to develop innovative treatments for various diseases. Over the years, ZymoGenetics made significant contributions to the field of biopharmaceuticals, focusing on areas such as autoimmunity, inflammation, and hemostasis.
In 2010, ZymoGenetics was acquired by Bristol-Myers Squibb for approximately $885 million, a move that aimed to bolster Bristol-Myers Squibb's pipeline with ZymoGenetics' promising experimental drugs and research capabilities in biologics.
Products and Research[edit | edit source]
ZymoGenetics' research efforts were primarily focused on protein therapeutics. One of its notable products was Recothrom, a recombinant version of human thrombin, used to control bleeding during surgery. This product exemplified the company's approach to developing biologics that could offer alternatives to traditional treatments.
The company's pipeline also included experimental treatments for autoimmune diseases and cancer, reflecting the broader industry trend towards targeted therapies that could offer improved efficacy and reduced side effects compared to conventional treatments.
Facilities[edit | edit source]
ZymoGenetics was headquartered in the iconic Lake Union Steam Plant building in Seattle, a landmark that symbolized the company's blend of historical roots and modern scientific ambition. The facility housed the company's research laboratories, administrative offices, and manufacturing operations, serving as a hub for its various activities.
Impact and Legacy[edit | edit source]
The acquisition of ZymoGenetics by Bristol-Myers Squibb marked the end of its independence but not its influence. The company's research and products continued to contribute to the biopharmaceutical industry, and its legacy lived on through its contributions to science and medicine. ZymoGenetics' work in the field of recombinant DNA technology and protein therapeutics remains a testament to the potential of biotechnology to address unmet medical needs.
See Also[edit | edit source]
 | This biotechnology article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
